Gene expression changes associated with erlotinib response in glioma cell lines.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Cancer

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejca.2013.01.002PMID 23374632
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

  2012cited by this paper
• A critical role for non-coding RNA GAS5 in growth arrest and rapamycin inhibition in human T-lymphocytes.

  2011cited by this paper
• National Comprehensive Cancer Network (NCCN) Head and Neck Cancers NCCN Clinical Practice Guidelines in Oncology . 2010.

  2011cited by this paper
• Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer

  2010cited by this paper
• Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.

  2010cited by this paper
• Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics

  2010cited by this paper
• A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas.

  2010cited by this paper
• A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.

  2010cited by this paper
• Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self‐Renewal and Tumorigenicity of Glioblastoma Stem‐Like Cells

  2010cited by this paper
• Noncoding RNA Gas5 Is a Growth Arrest– and Starvation-Associated Repressor of the Glucocorticoid Receptor

  2010cited by this paper
• NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas

  2009cited by this paper
• Therapeutic Inhibition of the Epidermal Growth Factor Receptor in High-Grade Gliomas: Where Do We Stand?

  2009cited by this paper
• Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigation.

  2009cited by this paper
• Combined inhibition of MEK and mammalian target of rapamycin abolishes phosphorylation of cyclin-dependent kinase 4 in glioblastoma cell lines and prevents their proliferation.

  2009cited by this paper
• Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies

  2009cited by this paper
• Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma

  2009cited by this paper
• Epithelial Growth Factor Receptor inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study

  2008cited by this paper
• Epidermal growth factor receptor pathway gene expressions and biological response of glioblastoma multiforme cell lines to erlotinib.

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• E2F1 in gliomas: a paradigm of oncogene addiction.

  2008cited by this paper
• Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.

  2008cited by this paper
• Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma

  2007cited by this paper
• Integrative Genomic Analysis of Phosphatidylinositol 3′-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• WHO classification of tumours of the central nervous system

  2007cited by this paper
• Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas

  2007cited by this paper
• BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations

  2007cited by this paper
• Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours.

  2006cited by this paper
• Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain

  2006cited by this paper
• Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer.

  2006cited by this paper
• E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell‐cycle arrest in response to ras inhibition

  2006cited by this paper
• Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.

  2006cited by this paper
• Glioblastoma multiforme and the epidermal growth factor receptor.

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

  2005cited by this paper
• Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

  2005cited by this paper
• Central nervous system cancers.

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• DNMAD: web-based diagnosis and normalization for microarray data

  2004cited by this paper
• DAVID: Database for Annotation, Visualization, and Integrated Discovery

  2003cited by this paper
• DAVID: Database for Annotation, Visualization, and Integrated Discovery

  2003cited by this paper

• Prognostic Value of MCM3AP-AS1 in Glioma and its Regulatory Effect on Tumor Progression

  2025cites this paper
• Characterization of growth arrest-specific transcript 5 and growth arrest-specific transcript 5-related m6A gene signature in glioma: An observational study

  2024cites this paper
• Expression of lncRNAs in glioma: A lighthouse for patients with glioma

  2024cites this paper
• ARPC5 acts as a potential prognostic biomarker that is associated with cell proliferation, migration and immune infiltrate in gliomas

  2023cites this paper
• Deciphering glioma epitranscriptome: focus on RNA modifications

  2023cites this paper
• Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells

  2022cites this paper
• Effect of folate-targeted Erlotinib loaded human serum albumin nanoparticles on tumor size and survival rate in a rat model of glioblastoma.

  2022cites this paper
• NVP-BEZ235 or JAKi Treatment leads to decreased survival of examined GBM and BBC cells.

  2021cites this paper
• Combination Therapy with PIK3R3-siRNA and EGFR-TKI Erlotinib Synergistically Suppresses Glioblastoma Cell Growth In Vitro

  2021influential citation
• Exosomal noncoding RNAs: key players in glioblastoma drug resistance

  2021cites this paper
• Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications

  2021influential citation
• The essential role of long non-coding RNA GAS5 in glioma: interaction with microRNAs, chemosensitivity and potential as a biomarker

  2021cites this paper
• Analysis and Simulation of Glioblastoma Cell Lines-Derived Extracellular Vesicles Metabolome

  2020cites this paper
• MiRNA-7 Replacement Effect on Proliferation and Tarceva-Sensitivity in U373-MG Cell Line

  2020cites this paper
• The Non-Coding RNA Repressor GAS5 of the Glucocorticoid Receptor: Insights to Its Role in Human Malignancies

  2020cites this paper
• MiRNA‐7 enhances erlotinib sensitivity of glioblastoma cells by blocking the IRS‐1 and IRS‐2 expression

  2020cites this paper
• Novel Tumor Suppressor lncRNA Growth Arrest-Specific 5 (GAS5) In Human Cancer

  2019cites this paper
• Growth arrest specific transcript 5 in tumorigenesis process: An update on the expression pattern and genomic variants.

  2019cites this paper
• Long non-coding RNA GAS5 promotes PC12 cells differentiation into Tuj1-positive neuron-like cells and induces cell cycle arrest

  2019cites this paper
• OTT_A_221305 8421..8436

  2019cites this paper
• Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing

  2018cites this paper
• Downregulation of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.

  2018cites this paper
• Association between long non-coding RNAs expression and pathogenesis and progression of gliomas

  2018cites this paper
• Identification of Novel Signal Transduction, Immune Function, and Oxidative Stress Genes and Pathways by Topiramate for Treatment of Methamphetamine Dependence Based on Secondary Outcomes

  2017cites this paper
• Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patients

  2017cites this paper
• An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas

  2017cites this paper
• Noncoding RNAs in Glioblastoma

  2017cites this paper
• Screening feature modules and pathways in glioma using EgoNet

  2017cites this paper
• Long non-coding RNA GAS5 controls human embryonic stem cell self-renewal by maintaining NODAL signalling

  2016cites this paper
• Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib

  2015cites this paper
• The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression

  2015cites this paper
• Epirubicin inhibits growth and alters the malignant phenotype of the U‑87 glioma cell line.

  2015cites this paper
• A critical role for the long non‐coding RNA GAS5 in proliferation and apoptosis in non‐small‐cell lung cancer

  2015cites this paper
• Gene co-expression network and function modules in three types of glioma.

  2015cites this paper
• Long non-coding RNAs in glioma: functional roles and clinical perspectives.

  2014cites this paper
• Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer

  2014cites this paper
• Tocotrienol-Rich Fraction, [6]-Gingerol and Epigallocatechin Gallate Inhibit Proliferation and Induce Apoptosis of Glioma Cancer Cells

  2014influential citation
• Small-molecule clinical trial candidates for the treatment of glioma.

  2014cites this paper